Product Information
GLIPIZIDE-METFORMIN 5-500 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1981 per EA under NDC 00093745701. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 28, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 500 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093745701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLIPIZIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077270FDA Approved
10/28/2005
TE Code
AB
On Market Since
10/28/2005
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE-METFORMIN 5-500 MG has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1981 per EA |
|---|---|
| All-time high | $0.5324 (Feb 10, 2016) |
| All-time low | $0.1588 (Jul 21, 2021) |
| 52-week high | $0.2224 |
| 52-week low | $0.1910 |
| Median price | $0.2711 |
| Average price | $0.3023 |
| Largest weekly change | +60.0% (Feb 23, 2022) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIPIZIDE-METFORMIN 5-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 5-500 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.1981 per EA (NDC 00093745701), effective Aug 19, 2026.
How has the price of GLIPIZIDE-METFORMIN 5-500 MG changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has declined 50.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 5-500 MG?
Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 5-500 MG has ranged from a low of $0.1588 (Jul 21, 2021) to a high of $0.5324 (Feb 10, 2016), with a median of $0.2711 per EA.
Are there cheaper alternatives to GLIPIZIDE-METFORMIN 5-500 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLIPIZIDE-METFORMIN 5-500 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures GLIPIZIDE-METFORMIN 5-500 MG?
GLIPIZIDE-METFORMIN 5-500 MG (NDC 00093745701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.